Dr. Emily Walden



Washington, DC
Tel: +1 202 466 9220
Fax: +1 202 466 3605

Email: emily.walden@nera.com
vCard: Download


PhD in economics, University of Wisconsin-Madison
BA in economics, Haverford College


Dr. Emily Walden is an expert in NERA’s Antitrust and Competition Practice. She has experience assessing the competitive effects of proposed mergers and acquisitions in a wide range of industries, including health care, oil and gas, and retail markets. Dr. Walden has conducted research on competition and antitrust issues and has published research on topics affecting these industries.

A long-time member of the American Bar Association, Dr. Walden currently serves as Chair of the Young Lawyers Division Antitrust Committee, Vice-Chair on the Antitrust Section Pricing Conduct Committee, and as the Young Lawyer Division Liaison to the Antitrust Section. She also served as Honorary Fellow for the University of Wisconsin, Madison’s Department of Population Health Sciences from 2017–2019.

Title Type Author
Economic Analysis and the Draft Merger Guidelines White Paper Robert Kulick and Emily Walden
Novel Privacy Concerns in Health Care Antitrust Published Article Dr. Andrew Stivers, Dr. Emily Walden, and Dr. Subramaniam (Subbu) Ramanarayanan
Non-Compete Agreements: Might They Be Procompetitive in Health Care? Published Article Dr. Paul Wong and Dr. Emily Walden
COVID-19 Merger Moratorium Could Hamper Vital Innovation Published Article Dr. Gabriella Monahova, Dr. Emily Walden, and Dr. Stephanie Demperio
Exclusive Dealing in Healthcare Published Article Dr. Emily Walden
A Closer Look at the Discount Attribution Test: An Economic Analysis for Evaluating t... Published Article Dr. Stephanie Demperio, Dr. Claire Chunying Xie, and Dr. Emily Walden
Weighing the Procompetitive and Anticompetitive Effects of RPM Under the Rule of Reas... Published Article Dr. Emily Walden and Dr. Stephanie Demperio
The Antitrust Revolution Book Dr. Graeme Hunter, Dr. Michael Baye, and Dr. Emily Walden